One of the side effects of ADT, as shown by a recent meta-analysis, is that it increases the risk of developing T2DM by 43% and hypertension by 30%, which might increase the risk of metabolic syndrome, but the association did not reach statistical significance [ 61 ].
← all excerpts
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist's Dual Role in Prostate Cancer.
1
—
—